Chemours (CC) Up 7.5% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 09/03/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CCPRNewsWire • 09/03/26
Cohen Milstein Sellers & Toll LLP - Chemours One Step Closer to Facing Jury Trial in Cape Fear River PFAS Class ActionGlobeNewsWire • 08/27/26
Chemours Publishes 2025 Sustainability Report Highlighting Progress on Climate, Emissions Reduction, and Responsible ManufacturingPRNewsWire • 08/25/26
Securities Fraud Investigation Into The Chemours Company (CC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmBusiness Wire • 08/13/26
The Chemours Company (CC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationBusiness Wire • 08/13/26
Chemours Launches Opteon™ ZE and Opteon™ 515B Refrigerants for Chiller Applications Powering Data Centers, Commercial Buildings, and Other Mission Critical EnvironmentsPRNewsWire • 08/10/26
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approvalReuters • 08/07/26
Chemours: Close To A 'Perfect' Rotation, With A 'Buy' In Q2 2026 (Rating Upgrade)Seeking Alpha • 08/06/26
Compared to Estimates, Chemours (CC) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/05/26
Chemours (CC) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 07/28/26
Chemours Announces Dates for Second Quarter 2026 Earnings Release and Webcast Conference CallPRNewsWire • 07/23/26